The global liver transplantation market is anticipated to exceed USD 1,409.8 million. By 2033, the market is projected to be valued approximately USD 2,653.4 million. It is projected that the liver transplant market would expand by 6.5% over the course of the forecast period.
For patients with severe liver failure, liver transplantation is a life-saving therapeutic option. It is also a necessary treatment for end-stage liver disease and some liver malignancies. Liver transplant therapies are expected to become more necessary as long as liver-related illnesses such cirrhosis, hepatitis, and non-alcoholic fatty liver disease remain major global health concerns.
Master Complexity: Request Your Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1281
The market for liver transplants is projected to expand in the near future, with significant contributions from treatment technique advancements. The market for liver transplants has expanded as a result of government and some private healthcare institutions’ reimbursement policies.
Weforum (2022) reports that over 130,000 organ transplants were performed in 2020, with kidneys being the most popular organ, followed by liver and heart. The liver transplant market is driven by several firms that create surgical tools and preservation procedures.
For instance, in June 2022, a Swiss medical team devised a new method to minimize the waiting period for organ transplants. Moreover, the surgeons developed a new technology to keep a damaged liver alive for a few days. However, the team is still observing the patient and working on the same for promising growth.
“New storage techniques for damaged livers and effective research and development in stem cells, tissue engineering, and organogenesis can lessen the transplant waiting list.
Key Takeaways :
- The North American region showed a 29.2% share of the liver transplantation market.
- European nations also show promising market demand in the liver transplantation market, with a share of 20.7%.
- Based on treatment type, liver transplantation surgery dominates the liver transplantation market with a 61.1% global revenue share.
- According to the forecast, 51% of liver transplantation surgeries are done in hospitals, while the rest are done in ambulatory and adult liver transplantation centers.
Recent Developments Detected by FMI in the Liver Transplantation Market:
- In 2022, Jaslok Hospital and Research Center in Mumbai saved two lives with a single liver transplantation surgery. This transplantation surgery, also known as split cadaver liver donation surgery, is where the liver is split into two. It was then used by both an adult and a pediatric recipient simultaneously.
- In August 2022, Integrated Graphene, with a team of scientists, developed an electrochemical biosensor to detect biliary complications in donor livers. The device, Gii-Sens, can detect the quality of the liver before transplantation. It can prevent the development of biliary complications and match the donor-recipient for transplant. According to the makers of Gii-Sens, the device is portable, economical, and responds fast to point-of-care diagnostics.
Key Players:
- Allosource
- Conatus Pharmaceuticals Inc.
- Digna Biotech S.L.
- Dompe Farmaceutici S.p.A.
- Isogenis, Inc.
- RedHill Biopharma Ltd.
- Thompson Surgical
- Integra Life Sciences
- Baxter International Inc.
- XVIVO
- VirTech Bio
- Vital Therapies
- HepaTx
- Humedics
Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-1281
Key Segments Profiled in the Global Liver Transplantation Market:
By Treatment Type:
- Liver Transplantation Surgery
- Post-Surgery Anti-Rejection Treatment
- Cyclosporine
- Tacrolimus
- Sirolimus Prednisone Azathioprine
- Mycophenolate Mofetil
By End Use:
- Hospitals
- Adult Liver Transplantation Centers
- Ambulatory Surgical Centers
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- The Middle East and Africa
Get Full Market Analysis Now: Purchase The Report:
https://www.futuremarketinsights.com/checkout/1281
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
